Progyny Inc (NASDAQ: PGNY) kicked off on Tuesday, down -0.18% from the previous trading day, before settling in for the closing price of $28.38. Over the past 52 weeks, PGNY has traded in a range of $23.90-$44.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 61.75%. While this was happening, its average annual earnings per share was recorded 15.77%. With a float of $81.85 million, this company’s outstanding shares have now reached $95.73 million.
Let’s determine the extent of company efficiency that accounts for 566 employees.
Progyny Inc (PGNY) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Progyny Inc is 14.04%, while institutional ownership is 90.81%. The most recent insider transaction that took place on Nov 23 ’24, was worth 11,258. In this transaction Director of this company sold 200 shares at a rate of $56.29, taking the stock ownership to the 580,656 shares. Before that another transaction happened on Jun 28 ’24, when Company’s Director sold 1,462 for $28.39, making the entire transaction worth $41,506. This insider now owns 10,098 shares in total.
Progyny Inc (PGNY) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 15.77% per share during the next fiscal year.
Progyny Inc (NASDAQ: PGNY) Trading Performance Indicators
Take a look at Progyny Inc’s (PGNY) current performance indicators. Last quarter, stock had a quick ratio of 3.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.43. Likewise, its price to free cash flow for the trailing twelve months is 14.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.61, a number that is poised to hit 0.17 in the next quarter and is forecasted to reach 0.96 in one year’s time.
Technical Analysis of Progyny Inc (PGNY)
Looking closely at Progyny Inc (NASDAQ: PGNY), its last 5-days average volume was 1.42 million, which is a jump from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 85.25%. Additionally, its Average True Range was 0.97.
During the past 100 days, Progyny Inc’s (PGNY) raw stochastic average was set at 24.37%, which indicates a significant decrease from 79.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.88% in the past 14 days, which was lower than the 48.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.70, while its 200-day Moving Average is $33.75. However, in the short run, Progyny Inc’s stock first resistance to watch stands at $28.57. Second resistance stands at $28.81. The third major resistance level sits at $29.09. If the price goes on to break the first support level at $28.05, it is likely to go to the next support level at $27.77. Now, if the price goes above the second support level, the third support stands at $27.53.
Progyny Inc (NASDAQ: PGNY) Key Stats
The company with the Market Capitalisation of 2.70 billion has total of 95,221K Shares Outstanding. Its annual sales at the moment are 1,089 M in contrast with the sum of 62,040 K annual income. Company’s last quarter sales were recorded 278,080 K and last quarter income was 16,900 K.
